On ECHEMI
Home > Drugs > Elastase Enteric-coated Capsules

Elastase Enteric-coated Capsules

Function and Efficacy

This product is an endopeptidase that can hydrolyze elastin, collagen and glycoprotein, enhance the activity of lipoprotein esterase, prevent the synthesis of cholesterol in the body and promote its conversion into bile acid, reduce plasma cholesterol, LDL, VLDL and triglycerides, increase HDL, prevent lipid deposition on the arterial wall, decompose old elastin and promote new elastin synthesis, maintain vascular elasticity, inhibit glomerular basement membrane hypertrophy, and reduce the excretion of trace protein in the kidney. The LD50 of intraperitoneal injection in mice is 101.6±14.1mg/kg. Dogs are given 300 units/kg orally and by injection respectively. After 4 weeks, no abnormalities were found in blood counts, liver function, kidney function and other biochemical indicators and pathological examinations. Mice were continuously given 750, 7500, and 75000 units/kg of this product by oral gavage during pregnancy, and no stillbirth or deformity was observed.

Ingredients

The main ingredient is elastase.

Name Description Content CAS NO. Manufacturer
ElastaseIngredients

This product is an endopeptidase that can hydrolyze elastin, collagen and glycoprotein, enhance the activity of lipoprotein esterase, prevent the synthesis of cholesterol in the body and promote its conversion into bile acid, reduce plasma cholesterol, LDL, VLDL and triglycerides, increase HDL, prevent lipid deposition on the arterial wall, decompose old elastin and promote the synthesis of new elastin, maintain vascular elasticity, inhibit the hypertrophy of glomerular basement membrane, and reduce the excretion of trace protein in the kidney.

More
39445-21-1 0

Appearance

Properties: This product is in the form of capsules. Without the capsule, it appears as off-white or light yellow powder or granules.

Indication

It is clinically used for type II and IV hyperlipidemia (especially type II), atherosclerosis, fatty liver, and diabetic nephropathy.

Usage and Dosage

Oral administration, 300-600 units at a time, 3 times a day.

Adverse Reactions

Occasionally, allergic reactions may occur, and mild gastrointestinal symptoms may occur, such as abdominal distension, loss of appetite, etc., and pain in the liver area, dry mouth, and numbness of the lips may also be seen. Generally, no treatment is required and it can heal on its own.

Precautions

Not yet clear.

Special Population Medication

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Drug Interactions

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Storage

seal.

Packaging Specification

100 units

Validity Period

24 months

Manufacturer

Shandong Xili Pharmaceutical Co., Ltd.

  • Founded in:

    2000-12-29
  • Address:

    Room 201, 2nd Floor, Xili Office Building, No. 2526, Huanghe East Road, Danyang Street, Luxi New District, Heze City, Shandong Province
  • Tax NO.:

    9137170016885208XA
  • Registered Funds:

    30 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.